BAYN PEER ANALYSIS

Bayer AG NA — metric-by-metric comparison with peers and the industry median

BAYNBayer AG NA

🇩🇪 Germany · XETRA · Healthcare · Drug Manufacturers - General

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - General

Position Within Industry

0 = weak quartile, 100 = strong quartile

BAYNIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	BAYN	SAN	BIIB	AZN	BMY	PFE	Ind. Median
P/E	—	8.76●	21.67	28.81	16.16	18.40	21.67
P/B	1.69	1.25●	1.59	6.32	5.86	1.53	4.52
EV/EBITDA	23.10	9.67●	11.85	15.97	11.03	11.30	13.66
P/S	1.08●	1.95	3.02	4.95	2.43	2.18	3.02

Financial Health
Metric	BAYN	SAN	BIIB	AZN	BMY	PFE	Ind. Median
Current Ratio	1.06	1.01	3.06●	0.91	1.42	1.25	1.25
Debt/Equity	134.8%	27.5%●	35.2%	71.7%	221.5%	71.5%	94.3%
NetDebt/EBITDA	9.19	1.33	0.84●	1.29	2.47	3.07	1.35

Profitability
Metric	BAYN	SAN	BIIB	AZN	BMY	PFE	Ind. Median
Net Margin	-4.8%	22.3%●	13.9%	17.2%	15.0%	11.8%	15.0%
ROE	-7.0%	14.1%	7.7%	23.5%	38.8%●	8.3%	23.7%
ROA	-2.0%	8.0%	4.8%	9.4%●	8.1%	3.6%	8.0%
EBITDA Margin	7.7%	23.4%	27.4%	33.7%●	28.4%	26.5%	28.4%

Growth + Dividend
Metric	BAYN	SAN	BIIB	AZN	BMY	PFE	Ind. Median
Rev. Growth	-2.9%	3.3%	0.4%	9.9%●	1.8%	1.4%	3.3%
NI Growth	—	59.8%●	-7.2%	33.7%	34.2%	-4.8%	32.9%
Div. Yield	0.2%	0.0%	—	0.2%	4.5%	7.2%●	2.1%
Payout	-5.9%	0.0%	—	47.3%	69.7%	130.5%	45.7%

Valuation
Metric	BAYN	MRK	SHL	FRE	FME	Ind. Median
P/E	—	23.88	18.38	16.18	12.23●	21.67
P/B	1.69	2.03	2.11	1.20	0.87●	4.52
EV/EBITDA	23.10	11.51	11.78	9.34	6.15●	13.66
P/S	1.08	2.89	1.67	1.03	0.60●	3.02

Financial Health
Metric	BAYN	MRK	SHL	FRE	FME	Ind. Median
Current Ratio	1.06	1.51●	1.10	1.27	1.20	1.25
Debt/Equity	134.8%	40.5%●	84.1%	60.2%	83.3%	94.3%
NetDebt/EBITDA	9.19	1.38●	3.04	2.73	2.82	1.35

Profitability
Metric	BAYN	MRK	SHL	FRE	FME	Ind. Median
Net Margin	-4.8%	12.1%●	9.1%	6.4%	4.9%	15.0%
ROE	-7.0%	8.5%	11.4%●	7.5%	6.8%	23.7%
ROA	-2.0%	4.9%●	4.6%	3.4%	2.9%	8.0%
EBITDA Margin	7.7%	28.5%●	19.1%	15.6%	17.9%	28.4%

Growth + Dividend
Metric	BAYN	MRK	SHL	FRE	FME	Ind. Median
Rev. Growth	-2.9%	-1.7%	-0.3%	4.2%●	-0.7%	3.3%
NI Growth	—	-10.1%	0.3%	248.3%●	52.9%	32.9%
Div. Yield	0.2%	1.5%	2.9%	2.5%	3.6%●	2.1%
Payout	-5.9%	11.8%	48.4%	46.3%	44.7%	45.7%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on BAYN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.